JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB219651

Anti-Axl 抗体 [EPR19880]

Anti-Axl antibody [EPR19880]

5

(1 Review)

|

(11 Publications)

Rabbit Recombinant Monoclonal Axl antibody. Suitable for WB, IHC-P and reacts with Human samples. Cited in 11 publications.

別名を表示する

UFO, AXL, Tyrosine-protein kinase receptor UFO, AXL oncogene

8 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Axl antibody [EPR19880] (AB219651)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Axl antibody [EPR19880] (AB219651)

Immunohistochemical analysis of paraffin-embedded human lung tissue labeling Axl with ab219651 at 1/4000 dilution, followed by Goat Anti-Rabbit IgG H&L (HRP) Ready to use. Sporadic cytoplasmic staining on human lung.

Counter stained with Hematoxylin.

Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) Ready to use.

Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Axl antibody [EPR19880] (AB219651)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Axl antibody [EPR19880] (AB219651)

Immunohistochemical analysis of paraffin-embedded human adipose tissue labeling Axl with ab219651 at 1/4000 dilution, followed by Goat Anti-Rabbit IgG H&L (HRP) Ready to use.

Negative control : No staining on human adipose tissues (PMID : 26573603).

Counter stained with Hematoxylin.

Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Axl antibody [EPR19880] (AB219651)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Axl antibody [EPR19880] (AB219651)

Immunohistochemical analysis of paraffin-embedded human breast and breast carcinoma tissue labeling Axl with ab219651 at 1/4000 dilution, followed by Goat Anti-Rabbit IgG H&L (HRP) Ready to use. Cytoplasmic staining on cancer cells of the human breast carcinoma, and the pericarcinous tissue was nearly negative (magnification x150) (PMID : 25337673).

Counter stained with Hematoxylin.

Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) Ready to use.

Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Axl antibody [EPR19880] (AB219651)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Axl antibody [EPR19880] (AB219651)

Immunohistochemical analysis of paraffin-embedded human lung carcinoma tissue labeling Axl with ab219651 at 1/4000 dilution, followed by Goat Anti-Rabbit IgG H&L (HRP) Ready to use. Cytoplasmic staining on cancer cells of human lung carcinoma (PMID : 25337673).

Counter stained with Hematoxylin.

Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) Ready to use.

Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.

Western blot - Anti-Axl antibody [EPR19880] (AB219651)
  • WB

Lab

Western blot - Anti-Axl antibody [EPR19880] (AB219651)

Blocking and diluting buffer and concentration : 5% NFDM/TBST.

ab219651 exhibits low sensitivity in western blot. It is recommended to use ab259831 or ab215205 as alternatives or to optimize experimental conditions by increasing the sample loading amount, using a lower antibody dilution ratio, and employing femtogram-level sensitivity substrates.

Lanes 1 - 3:

Western blot - Anti-Axl antibody [EPR19880] (ab219651) at 1/1000 dilution

Lanes 5 - 7:

Western blot - Anti-Axl antibody [EPR23892-15] (<a href='/products/primary-antibodies/axl-antibody-epr23892-15-ab259831'>ab259831</a>) at 1/1000 dilution

Lanes 9 - 11:

Western blot - Anti-Axl antibody [EPR21107] (<a href='/products/primary-antibodies/axl-antibody-epr21107-ab215205'>ab215205</a>) at 1/1000 dilution

Lanes 1, 5 and 9:

HeLa (human cervix adenocarcinoma epithelial cell) whole cell lysate 20 µg

Lanes 2, 6 and 9:

HUVEC (human umbilical vein endothelial cell line) whole cell lysate 20 µg

Lanes 3, 7 and 11:

A549 (Human lung carcinoma epithelial cell) whole cell lysate 20 µg

Lanes 4, 8 and 12:

Jurkat (human T cell leukemia cell line from peripheral blood) whole cell lysate at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Predicted band size: 98 kDa

Observed band size: 80 kDa,140 kDa

false

Exposure time: 180s

Western blot - Anti-Axl antibody [EPR19880] (AB219651)
  • WB

Supplier Data

Western blot - Anti-Axl antibody [EPR19880] (AB219651)

All lanes:

Western blot - Anti-AXL (phospho Y702) + MERTK (phospho Y753) + TYRO3 (phospho Y685) antibody [EPR26140-66] (<a href='/products/primary-antibodies/axl-phospho-y702-mertk-phospho-y753-tyro3-phospho-y685-antibody-epr26140-66-ab302718'>ab302718</a>) at 1/1000 dilution

Lane 1:

Untreated NCI-H1299 whole cell lysate (Untreated membrane)

Lane 2:

NCI-H1299 treated with 100 ng/ml Gas6 for 10 minutes, whole cell lysate (Untreated membrane)

Lane 3:

NCI-H1299 treated with 10mM pervanadate for 10 minutes, whole cell lysate (Untreated membrane) at 40 µg

Lane 4:

NCI-H1299 treated with 100 ng/ml Gas6 and 10mM pervanadate for 10 minutes, whole cell lysate (Untreated membrane) at 40 µg

Lane 5:

Untreated NCI-H1299 whole cell lysate (Phosphatase treated membrane)

Lane 6:

NCI-H1299 treated with 100 ng/ml Gas6 for 10 minutes, whole cell lysate (Phosphatase treated membrane)

Lane 7:

NCI-H1299 treated with 10mM pervanadate for 10 minutes, whole cell lysate (Phosphatase treated membrane)

Lane 8:

NCI-H1299 treated with 100 ng/ml Gas6 and 10mM pervanadate for 10 minutes, whole cell lysate (Phosphatase treated membrane)

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Observed band size: 138 kDa

true

Exposure time: 136s

Western blot - Anti-Axl antibody [EPR19880] (AB219651)
  • WB

Supplier Data

Western blot - Anti-Axl antibody [EPR19880] (AB219651)

Blocking/Dilution buffer : 5% NFDM/TBST.

Detection of endogenous expression of Axl in WB will need optimization. Under our experimental conditions we could not detect endogenous Axl in human cell and tissue lysates.

All lanes:

Western blot - Anti-Axl antibody [EPR19880] (ab219651) at 1/10000 dilution

Lane 1:

293T (Human epithelial cell line from embryonic kidney) transfected with an empty expression vector, whole cell lysate at 10 µg

Lane 2:

293T (Human epithelial cell line from embryonic kidney) transfected with a His-tagged human Axl construct whole cell lysate at 10 µg

Secondary

All lanes:

Goat Anti-Rabbit IgG, (H+L), Peroxidase at 1/100000 dilution

Predicted band size: 98 kDa

Observed band size: 138 kDa

false

Exposure time: 5s

Western blot - Anti-Axl antibody [EPR19880] (AB219651)
  • WB

Supplier Data

Western blot - Anti-Axl antibody [EPR19880] (AB219651)

All lanes:

Western blot - Anti-AXL (phospho Y702) + MERTK (phospho Y753) + TYRO3 (phospho Y685) antibody [EPR26140-66] (<a href='/products/primary-antibodies/axl-phospho-y702-mertk-phospho-y753-tyro3-phospho-y685-antibody-epr26140-66-ab302718'>ab302718</a>) at 1/1000 dilution

Lane 1:

Untreated 293T cells transfected with a human AXL expression vector containing a myc-His-tag® lysate

Lane 2:

Gas6/pervanadate treated 293T cells transfected with a human AXL expression vector containing a myc-His-tag®

Lane 3:

Untreated 293T cells transfected with a human AXL(Y702A mutant) expression vector containing a myc-His-tag® lysate

Lane 4:

Gas6/pervanadate 293T cells transfected with a human AXL(Y702A mutant) expression vector containing a myc-His-tag®

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Observed band size: 138 kDa

false

Exposure time: 180s

関連する標識済み抗体及び組成の異なる製品 (1)

  • Carrier free

    Anti-Axl antibody [EPR19880] - BSA and Azide free

Key facts

宿主種

Rabbit

クローン性

Monoclonal

クローン番号

EPR19880

アイソタイプ

IgG

キャリアフリー

No

交差種

Human

アプリケーション

IHC-P, WB

applications

免疫原

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/10000", "WB-species-notes": "<p>Detection of endogenous expression of AXL in WB will need optimization. Under our experimental conditions we could not detect endogenous AXL in human cell and tissue lysates.</p><p>ab219651 exhibits low sensitivity in western blot. It is recommended to use <a href='/products/primary-antibodies/axl-antibody-epr23892-15-ab259831'>ab259831</a> or <a href='/products/primary-antibodies/axl-antibody-epr21107-ab215205'>ab215205</a> as alternatives or to optimize experimental conditions by increasing the sample loading amount, using a lower antibody dilution ratio, and employing femtogram-level sensitivity substrates.</p>", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/4000", "IHCP-species-notes": "<p></p>" } } }

製品の詳細

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

出荷温度及び保存条件

製品の状態
Liquid
精製方法
Affinity purification Protein A
バッファー組成
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
出荷温度
Blue Ice
短期保存期間
1-2 weeks
短期保存温度
+4°C
長期保存温度
-20°C
分注に関する情報
Upon delivery aliquot
保管に関する情報
Avoid freeze / thaw cycle

補足情報

This supplementary information is collated from multiple sources and compiled automatically.

The Axl protein also known as AXL receptor tyrosine kinase plays a significant role in cell signaling. It has a molecular weight of approximately 98 kDa. Axl is a transmembrane receptor that is expressed in a variety of tissues including the immune system reproductive organs and the central nervous system. It is mainly recognized for transmitting signals from the extracellular matrix into the cytoplasm by binding with its ligand Gas6.
Biological function summary

Axl is important in mediating cell survival proliferation and migration. It functions as part of the TAM family of receptors which also includes Tyro3 and Mer. Axl often forms complexes with these receptors to facilitate efficient signaling. This interaction triggers phosphorylation events that activate downstream signaling proteins reinforcing its influence in cellular functions.

Pathways

Axl is deeply involved in the PI3K-Akt and MAPK signaling pathways which are central to cellular growth and survival. In these pathways Axl interacts closely with proteins like PI3K and Akt to regulate processes such as apoptosis and metabolism. Its interaction with these pathways places Axl as an important modulator of intracellular signaling cascades.

Axl has been implicated in cancer progression and immune response dysregulation. In many cancer types Axl overexpression links to tumor invasion metastasis and resistance to therapy. Moreover Axl’s role in autoimmune diseases becomes evident through its association with the Gas6 protein. Exploring these connections furthers understanding of how Axl's aberrant activity influences health and disease.

製品プロトコール

For this product, it's our understanding that no specific protocols are required. You can visit:

ターゲットの情報

Receptor tyrosine kinase that transduces signals from the extracellular matrix into the cytoplasm by binding growth factor GAS6 and which is thus regulating many physiological processes including cell survival, cell proliferation, migration and differentiation. Ligand binding at the cell surface induces dimerization and autophosphorylation of AXL. Following activation by ligand, AXL binds and induces tyrosine phosphorylation of PI3-kinase subunits PIK3R1, PIK3R2 and PIK3R3; but also GRB2, PLCG1, LCK and PTPN11. Other downstream substrate candidates for AXL are CBL, NCK2, SOCS1 and TNS2. Recruitment of GRB2 and phosphatidylinositol 3 kinase regulatory subunits by AXL leads to the downstream activation of the AKT kinase. GAS6/AXL signaling plays a role in various processes such as endothelial cell survival during acidification by preventing apoptosis, optimal cytokine signaling during human natural killer cell development, hepatic regeneration, gonadotropin-releasing hormone neuron survival and migration, platelet activation, or regulation of thrombotic responses. Also plays an important role in inhibition of Toll-like receptors (TLRs)-mediated innate immune response.. (Microbial infection) Acts as a receptor for lassa virus and lymphocytic choriomeningitis virus, possibly through GAS6 binding to phosphatidyl-serine at the surface of virion envelope.. (Microbial infection) Acts as a receptor for Ebolavirus, possibly through GAS6 binding to phosphatidyl-serine at the surface of virion envelope.. (Microbial infection) Promotes Zika virus entry in glial cells, Sertoli cells and astrocytes (PubMed : 28076778, PubMed : 29379210, PubMed : 31311882). Additionally, Zika virus potentiates AXL kinase activity to antagonize type I interferon signaling and thereby promotes infection (PubMed : 28076778). Interferon signaling inhibition occurs via an SOCS1-dependent mechanism (PubMed : 29379210).
See full target information AXL

文献 (11)

Recent publications for all applications. Explore the full list and refine your search

Signal transduction and targeted therapy 10:280 PubMed40887473

2025

Focal adhesion kinase/Src family kinase axis-mediated tyrosine phosphorylation of metabolic enzymes facilitates tumor metastasis.

Applications

Unspecified application

Species

Unspecified reactive species

Jie Chen,Jing Zhang,Yuheng Zhu,Yanmeng Zhu,Jingyuan Pang,Qingnan Wu,Yan Wang,Qimin Zhan

Diagnostic pathology 20:46 PubMed40241101

2025

The ability of anexelekto (AXL) expression and TERT promoter mutation to predict radioiodine-refractory differentiated thyroid carcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Hasrayati Agustina,Tutik Nur Ayni,Yohana Azhar,Erwin Affandi Soeriadi,Bethy Suryawathy Hernowo

Nature communications 16:1477 PubMed39929832

2025

Multi-omics analyses reveal biological and clinical insights in recurrent stage I non-small cell lung cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Chengdi Wang,Jingwei Li,Jingyao Chen,Zhoufeng Wang,Guonian Zhu,Lujia Song,Jiayang Wu,Changshu Li,Rong Qiu,Xuelan Chen,Li Zhang,Weimin Li

Anticancer research 45:639-650 PubMed39890197

2025

Efficacy of Second-line Nivolumab Tyrosine Kinase Inhibitors for Renal Cell Carcinoma With Bone Metastases.

Applications

Unspecified application

Species

Unspecified reactive species

Gaku Yamamichi,Taigo Kato,Akihiro Yoshimura,Masaru Tani,Yuki Horibe,Yutong Liu,Nesrine Sassi,Yohei Okuda,Toshiki Oka,Toshihiro Uemura,Akinaru Yamamoto,Y U Ishizuya,Takuji Hayashi,Yoshiyuki Yamamoto,Koji Hatano,Atsunari Kawashima,Tetsuya Takao,Kensaku Nishimura,Shingo Takada,Masao Tsujihata,Norio Nonomura

British journal of cancer 131:589-600 PubMed38886556

2024

Aberrant activation of AXL may drive progression of squamous cell carcinoma in CLL patients: a mechanistic study with clinical implications.

Applications

Unspecified application

Species

Unspecified reactive species

Sutapa Sinha,Ray Guo,Miles D Del Busso,Weiguo Han,Justin Boysen,Linda E Wellik,Asish K Ghosh,Neil E Kay

Biomedicines 11: PubMed37239141

2023

Targeting of microRNA-22 Suppresses Tumor Spread in a Mouse Model of Triple-Negative Breast Cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Riccardo Panella,Cody A Cotton,Valerie A Maymi,Sachem Best,Kelsey E Berry,Samuel Lee,Felipe Batalini,Ioannis S Vlachos,John G Clohessy,Sakari Kauppinen,Pier Paolo Pandolfi

Aging 15:3715-3737 PubMed37166426

2023

Plasmon-activated water as a therapeutic strategy in Alzheimer's disease by altering gut microbiota.

Applications

Unspecified application

Species

Unspecified reactive species

Chia-Hsiung Cheng,Yu-Chuan Liu,Yu-Chen S H Yang,Kun-Ju Lin,Dean Wu,Yun-Ru Liu,Chun-Chao Chang,Chien-Tai Hong,Chaur-Jong Hu

Frontiers in immunology 13:840785 PubMed35464443

2022

Comprehensive Oncogenic Features of Coronavirus Receptors in Glioblastoma Multiforme.

Applications

Unspecified application

Species

Unspecified reactive species

Anjing Chen,Wenguo Zhao,Xiaolong Li,Guangyu Sun,Zhaoyin Ma,Lingyu Peng,Zhongyang Shi,Xingang Li,Jie Yan

Cancer discovery 11:1952-1969 PubMed33707236

2021

Intrinsic Immunogenicity of Small Cell Lung Carcinoma Revealed by Its Cellular Plasticity.

Applications

Unspecified application

Species

Unspecified reactive species

Navin R Mahadevan,Erik H Knelson,Jacquelyn O Wolff,Amir Vajdi,Maria Saigí,Marco Campisi,Deli Hong,Tran C Thai,Brandon Piel,Saemi Han,Bruce B Reinhold,Jonathan S Duke-Cohan,Michael J Poitras,Luke J Taus,Patrick H Lizotte,Andrew Portell,Victor Quadros,Alison D Santucci,Takahiko Murayama,Israel Cañadas,Shunsuke Kitajima,Aoi Akitsu,Maya Fridrikh,Hideo Watanabe,Brendan Reardon,Prafulla C Gokhale,Cloud P Paweletz,Mark M Awad,Eliezer M Van Allen,Ana Lako,Xi-Tao Wang,Benjamin Chen,Fangxin Hong,Lynette M Sholl,Michael Y Tolstorukov,Kathleen Pfaff,Pasi A Jänne,Evisa Gjini,Robin Edwards,Scott Rodig,Ellis L Reinherz,Matthew G Oser,David A Barbie

Cell research 31:126-140 PubMed33420426

2021

AXL is a candidate receptor for SARS-CoV-2 that promotes infection of pulmonary and bronchial epithelial cells.

Applications

Unspecified application

Species

Unspecified reactive species

Shuai Wang,Zongyang Qiu,Yingnan Hou,Xiya Deng,Wei Xu,Tingting Zheng,Peihan Wu,Shaofang Xie,Weixiang Bian,Chong Zhang,Zewei Sun,Kunpeng Liu,Chao Shan,Aifu Lin,Shibo Jiang,Youhua Xie,Qiang Zhou,Lu Lu,Jing Huang,Xu Li
View all publications

Abcam product promise

当社は、高品質な試薬を通じてお客様の研究を力強くサポートすることをお約束いたします。ご使用いただく各段階で、常にお客様をサポートできる体制を整えております。万が一、製品が期待通りに機能しない場合は、「Abcam Product Promise」による当社保証制度に基づき、安心してご利用いただけます。
保証に関する詳細については利用規約をご確認ください。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com